OncoGenex Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript

OncoGenex Pharmaceuticals, Inc. (OGXI)

Q1 2010 Earnings Call Transcript

May 6, 2010 4:30 pm ET

Executives

Jason Spark – IR

Scott Cormack – President and CEO

Cameron Lawrence – Principal Financial Officer

Cindy Jacobs – EVP and Chief Medical Officer

Analysts

Simos Simeonidis – Rodman & Renshaw

Stephen Willey – Thomas Weisel Partners

Mark Monane – Needham & Company

Ted Tenthoff – Piper Jaffray

Presentation

Operator

» Broadridge Financial Solutions, Inc. F3Q10 (Qtr End 03/31/10) Earnings Call Transcript
» Beiersdorf AG Q1 2010 Earnings Call Transcript
» TravelCenters of America LLC Q1 2010 Earnings Call Transcript

Good day, ladies and gentlemen and welcome to the OncoGenex first quarter 2010 conference call. At this time, all participants are in a listen-only mode. Later we will conduct question-and-answer session and instructions will follow at that time. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Jason Spark. You may begin.

Jason Spark

Thank you. Good afternoon, everyone. Thank you for joining us for OncoGenex Pharmaceuticals first quarter conference call. The company issued a press release today containing a financial results for the first quarter and three months ended March 31 2010 as well as the review of the company's highlights for the first quarter of 2010. This release is available on the Investor Relations’ page of the company's website at www.oncogenex.com. As a reminder, this call is being and broadcast live on Investor Relation page of the company’s website and the replay of the webcast will be available for 90 days.

Before we begin, I would like to remind everyone that some of the statements made today include predictions, estimates and other information that might be considered forward-looking. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially from our predictions and estimates, as a result of various risk factors, including those identified in our Annual Report on Form 10-K for 2009 filed on March 8, 2010 and our quarterly report on Form 10-Q filed earlier today, copies of which can be accessed on our website.